Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia

Clinical trial NCT02833844 · COMPLETED

Trial details

NCT number: NCT02833844
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Subjects With Hyperlipidemia, Dyslipidemia and HIV Infection

Start date: 2017-05-22
Primary completion: 2019-07-09
Enrollment: 467

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.